Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $57.5000 (-4.17%) ($57.5000 - $70.0000) on Tue. Feb. 5, 2013. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 22.63% (three month average) | RSI | 32 | Latest Price | $57.5000(-4.17%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -1.7% a day on average for past five trading days. | Weekly Trend | CAPR declines -12.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(5%) IWM(4%) EWP(3%) XAR(3%) XLY(3%) | Factors Impacting CAPR price | CAPR will decline at least -11.315% in a week (0% probabilities). IGOV(-2%) EMHY(-2%) REMX(-1%) EWY(-1%) XLU(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -11.315% (StdDev 22.63%) | Hourly BBV | 0 () | Intraday Trend | -4.2% | | | |
|
Resistance Level | $60.64 | 5 Day Moving Average | $59(-2.54%) | 10 Day Moving Average | $58.55(-1.79%) | 20 Day Moving Average | $60.64(-5.18%) | To recent high | -37.8% | To recent low | 342.3% | Market Cap | $1.133b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |